Viatris Announces Financial Reporting Date for Q4 2025
Pittsburgh — Viatris Inc. (NASDAQ: VTRS), a leading global healthcare company, has stated it will report its financial results for the fourth quarter and full year of 2025. This important announcement is scheduled for the morning of February 26, 2026, along with an engaging webcast for investors and the general public.
Join the Live Webcast
On the day of the financial report, executives at Viatris will host a live webcast at 8:30 a.m. ET. During this session, they will discuss the financial results and address any inquiries from shareholders and analysts. It's a valuable opportunity for those interested in the company's performance and future direction.
Upcoming Investor Event Scheduled
In addition to the quarterly results, Viatris has planned an Investor Event on March 19, 2026, in New York City. This event is designed to further engage with analysts and institutional investors, who will receive dedicated invitations for pre-registration. More information will be shared during the February call, ensuring all interested parties stay informed.
Engage with Viatris
Investors are encouraged to access the live webcast at investor.viatris.com or dial in via phone for direct participation. For those unable to attend, a replay will be available on the website afterward. This initiative underscores Viatris' commitment to transparency and communication with the investment community.
About Viatris
Viatris Inc. (NASDAQ: VTRS) operates in a pivotal role in healthcare, aiming to merge the benefits of generics and branded medications to satisfy healthcare needs worldwide. With a mission focused on empowering individuals to lead healthier lives at all stages, Viatris is dedicated to providing accessible, high-quality medicines, serving nearly one billion patients annually worldwide.
Headquartered in the United States, Viatris boasts a global presence with significant centers located in Pittsburgh, Shanghai, and Hyderabad, India. The company continuously optimizes its extensive and diverse portfolio of medicines to tackle persistent health challenges across the globe. Through its unique supply chain and scientific expertise, Viatris ensures that access to medicines remains meaningful and impactful.
For more information about Viatris, its offerings, and updates, interested individuals can visit viatris.com and investor.viatris.com. They can also connect through LinkedIn, Instagram, YouTube, and X for the latest news and insights.
Frequently Asked Questions
What financial results will Viatris report in February 2026?
Viatris will report its fourth quarter and full year 2025 financial results during an earnings call on February 26, 2026.
How can I join the Viatris earnings webcast?
You can join the earnings webcast on the Viatris investor website at investor.viatris.com on the day of the announcement.
When is the investor event hosted by Viatris?
The investor event will take place on March 19, 2026, in New York City, with further details revealed during the February earnings call.
What is the mission of Viatris Inc.?
Viatris is dedicated to empowering people worldwide by providing high-quality medicines and improving healthcare access at every stage of life.
Where is Viatris headquartered?
Viatris is headquartered in the United States, with additional offices in Pittsburgh, Shanghai, and Hyderabad, India.
